Liven Pharma Limited (PSX:LIVEN)
Pakistan · Delayed Price · Currency is PKR 52.05
-0.03 (-0.06%)
At close: Jan 9, 2026
Liven Pharma Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 5.07 | 7.88 | 24.96 | 0.03 | 0.03 | 0.05 | Upgrade |
Cash & Short-Term Investments | 5.07 | 7.88 | 24.96 | 0.03 | 0.03 | 0.05 | Upgrade |
Cash Growth | -82.73% | -68.41% | 92385.38% | 0.20% | -44.73% | -12.81% | Upgrade |
Receivables | 10.35 | 9.4 | 101.02 | - | - | - | Upgrade |
Inventory | 109.88 | 123.32 | 123.78 | - | - | - | Upgrade |
Prepaid Expenses | 11.24 | 0.06 | 0.07 | - | - | - | Upgrade |
Other Current Assets | - | 7.28 | 10.45 | - | - | 0.4 | Upgrade |
Total Current Assets | 136.54 | 147.95 | 260.28 | 0.03 | 0.03 | 0.45 | Upgrade |
Property, Plant & Equipment | 660.51 | 666.51 | 665.55 | 131.45 | 144.55 | 159.1 | Upgrade |
Other Intangible Assets | 7.53 | 8.44 | 1.4 | - | - | - | Upgrade |
Other Long-Term Assets | - | - | - | 0.03 | 0.03 | 0.03 | Upgrade |
Total Assets | 804.57 | 822.9 | 927.23 | 131.5 | 144.6 | 159.58 | Upgrade |
Accounts Payable | 72.07 | 38.7 | 14.03 | - | 0 | 0.07 | Upgrade |
Accrued Expenses | 0.37 | 21.8 | 5.4 | 0.78 | 0.92 | 0.55 | Upgrade |
Short-Term Debt | 29.4 | 25.23 | 155.16 | 237.62 | 235.35 | 233.11 | Upgrade |
Current Portion of Long-Term Debt | 2.63 | 2.5 | 0.29 | - | - | - | Upgrade |
Current Portion of Leases | 0.61 | 0.59 | 0.4 | - | - | - | Upgrade |
Other Current Liabilities | - | 1.61 | 1.2 | - | - | - | Upgrade |
Total Current Liabilities | 105.08 | 90.43 | 176.48 | 238.4 | 236.27 | 233.74 | Upgrade |
Long-Term Debt | 4.21 | 5.1 | 1.06 | - | - | - | Upgrade |
Long-Term Leases | 1.08 | 1.25 | - | - | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | 90.5 | 92.27 | - | 15.72 | 18.62 | 21.84 | Upgrade |
Total Liabilities | 200.87 | 189.04 | 177.54 | 254.12 | 254.89 | 255.58 | Upgrade |
Common Stock | 930.4 | 930.4 | 0.4 | 121.24 | 121.24 | 121.24 | Upgrade |
Retained Earnings | -326.7 | -296.54 | 159.78 | -288.3 | -283.07 | -276.67 | Upgrade |
Comprehensive Income & Other | - | - | 589.51 | 44.44 | 51.54 | 59.43 | Upgrade |
Shareholders' Equity | 603.7 | 633.86 | 749.69 | -122.62 | -110.29 | -96 | Upgrade |
Total Liabilities & Equity | 804.57 | 822.9 | 927.23 | 131.5 | 144.6 | 159.58 | Upgrade |
Total Debt | 37.93 | 34.67 | 156.91 | 237.62 | 235.35 | 233.11 | Upgrade |
Net Cash (Debt) | -32.87 | -26.78 | -131.95 | -237.59 | -235.32 | -233.06 | Upgrade |
Net Cash Per Share | -0.37 | -0.38 | -3298.85 | -19.60 | -19.41 | -19.22 | Upgrade |
Filing Date Shares Outstanding | 93.04 | 93.04 | 12.12 | 12.12 | 12.12 | 12.12 | Upgrade |
Total Common Shares Outstanding | 93.04 | 93.04 | 12.12 | 12.12 | 12.12 | 12.12 | Upgrade |
Working Capital | 31.46 | 57.53 | 83.8 | -238.37 | -236.24 | -233.29 | Upgrade |
Book Value Per Share | 6.49 | 6.81 | 61.84 | -10.11 | -9.10 | -7.92 | Upgrade |
Tangible Book Value | 596.17 | 625.42 | 748.29 | -122.62 | -110.29 | -96 | Upgrade |
Tangible Book Value Per Share | 6.41 | 6.72 | 61.72 | -10.11 | -9.10 | -7.92 | Upgrade |
Land | 105.75 | 105.75 | 105.78 | 13.55 | 13.55 | 13.55 | Upgrade |
Buildings | 247.95 | 247.95 | 247.95 | 174.88 | 174.88 | 174.88 | Upgrade |
Machinery | 434.72 | 434.5 | 407.66 | 108.93 | 108.93 | 108.93 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.